FDA Approves Biosimilar That Can Treat Crohn's Disease, Psoriasis

The FDA has approved Wezlana, a biosimilar of Stelara, to treat a variety of rheumatic conditions, including psoriatic arthritis, Crohn's disease, and plaque psoriasis.

November 7, 2023 Today's top story FDA Approves Biosimilar That Can Treat Crohn's Disease, Psoriasis The FDA has approved Wezlana, a biosimilar of Stelara, to treat a variety of rheumatic conditions, including psoriatic arthritis, Crohn's disease, and plaque psoriasis. Read on       These 8 Habits Can Reduce Your Biological Age Up to 6 Years Read ON   How Poor Oral Health Disproportionately Affects Underserved Communities READ MORE   Having False-Positive Mammogram Result Linked to Increased Breast Cancer Risk Years Later Read ON   Cannabis Use Linked with Increased Risk of Heart Attack, Stroke Read ON   More top Reads       Advertisement Start a custom weight loss program Noom helps you adopt healthy habits so you can lose weight and keep it off. GET STARTED

View in browser Did a friend send you this email? Subscribe here. To see all newsletters, click here. Privacy  |  Unsubscribe Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health. © 2023 Healthline Media LLC 275 7th Ave., 24th Floor New York, NY 10001